Navigation Links
American Heart Journals Publishes Results From ERATO Trial Showing Dronedarone (Multaq(R)) Improves Ventricular Rate Control in Patients With Permanent Atrial Fibrillation
Date:8/31/2008

MONTPELLIER, France, September 1 /PRNewswire/ -- The ERATO study published today in the American Heart Journal demonstrated, for the first time in patients with permanent atrial fibrillation, that dronedarone (Multaq(R)) significantly reduces mean 24 hour ventricular rate, on top of other rate control agents. The mean heart rate reduction was 11.7 beats per minute (p< 0, 0001) with dronedarone compared to placebo, which is clinically relevant and highly statistically significant. This rate-controlling effect of dronedarone was sustained throughout the six-month trial and was additive to the effect of other rate control therapies. Dronedarone also significantly reduced maximal exercise heart rate by 24.5 beats per minute (p<0,0001) without impairing exercise capacity. Dronedarone was well tolerated with no evidence of organ toxicity or proarrhythmia over six months.

"Effective control of ventricular rate in patients with permanent AF is associated with significant improvements in both symptom control and clinical outcomes," explained principal investigator Jean-Marc Davy of Departement de Cardiologie, CHU Montpellier, France.

AF is the most frequent cardiac rhythm disorder and can be classified into three types: paroxysmal (self-limiting), persistent (responsive to cardioversion) or permanent (continuous atrial fibrillation with cardioversion proven or deemed ineffective). In patients with permanent AF (a substantial subset of the AF population), the only available therapeutic option is to control the ventricular response rate to prevent deterioration of the ventricular function and to minimise the symptoms (rate control strategy). Existing rate control agents (beta blockers, calcium channel blockers and cardiac glycosides) do not always achieve targeted heart rate, mainly due to the poor tolerability of high doses. In that regard, adequate rate control was only achieved in 64% of patients in the AFFIRM trial. Therefore additional therapeutic opt
'/>"/>

SOURCE CHU Montpellier
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. American Lung Association Study Finds No Evidence of Depression or Suicide Linked to Asthma and Allergy Drug Montelukast
2. Journal of the American Dental Association Publishes Key Clinical Data for the Use of OraVerse(TM) a Local Anesthetic Reversal Agent
3. Alzheimers Foundation of America Survey: Americans With Memory Concerns Fall Short of Talking to Doctors
4. Groundbreaking American Journal of Play from Strong National Museum of Play(R) Premiers July 2008
5. Genaera Corporation Presents Data on Mechanism of Inhibition of PTP-1B for Trodusquemine (MSI-1436) at Federation of American Societies for Experimental Biology (FASEB) Meeting
6. Data Presented at American Headache Societys Annual Scientific Meeting Show Primary Endpoint Met as Well as Improvement on Important Secondary Endpoints in Phase IIb Acute Migraine Trial of TorreyPines Therapeutics Tezampanel
7. MAP Pharmaceuticals Reports Positive Pharmacological Response Data for Migraine Product Candidate at the American Headache Society Annual Meeting
8. Headache Specialists Convene in Boston For 50th Annual American Headache Society Meeting
9. Alexza Pharmaceuticals to Present AZ-104 Phase 2a Clinical Data at the American Headache Society Annual Scientific Meeting
10. Results From One-Year Study Suggest Advair(R) Provides Important Benefits for African American Patients With Asthma
11. Genaera Corporation Presents Additional Promising Preclinical Type 2 Diabetes Data for Trodusquemine (MSI-1436) at American Diabetes Association

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)..., , TORONTO, Nov. 30 The S...on Inc. ("Patheon" or the "Company") (TSX: PTI) an...n Holdings, LLC (collectively, "JLL"), today annou...settlement agreement in respect of the pending leg...ment provides among other things that: ,, unti...
(Date:11/30/2009)..., , SCOTTSDALE, Ariz., Nov. 30 /PRNe... the leading provider of radiology solutions to ra... States, has implemented a redesigned Quality Assu...between NightHawk,s radiologists and customers and...wk will be providing an overview of the new QA pro...
(Date:11/30/2009)..., , NEW YORK, Nov. 30 /PRNewswire/ ...search report is available in its catalogue: ,,..., http://www.reportlinker.com/p0164299/Surgical-I...cal incision closures market holds enormous signif... being performed each year. Surgical disciplines s...
Breaking Medicine Technology:Patheon and JLL Partners Announce Litigation Settlement 2Patheon and JLL Partners Announce Litigation Settlement 3NightHawk Radiology Launches Redesigned Quality Assurance Program 2Reportlinker Adds Surgical Incision Closures - Global Trends 2Reportlinker Adds Surgical Incision Closures - Global Trends 3Reportlinker Adds Surgical Incision Closures - Global Trends 4Reportlinker Adds Surgical Incision Closures - Global Trends 5Reportlinker Adds Surgical Incision Closures - Global Trends 6Reportlinker Adds Surgical Incision Closures - Global Trends 7AFB Senior Site Offers New Information to Help Senior Citizens Manage Diabetes and Vision Loss 61313 1AFB Senior Site Offers New Information to Help Senior Citizens Manage Diabetes and Vision Loss 61313 2AFB Senior Site Offers New Information to Help Senior Citizens Manage Diabetes and Vision Loss 61313 3AFB Senior Site Offers New Information to Help Senior Citizens Manage Diabetes and Vision Loss 61313 4Misonix Announces New Distribution Agreement For The United Arab Emirates 28UAE 29 6255 1Misonix Announces New Distribution Agreement For The United Arab Emirates 28UAE 29 6255 2Misonix Announces New Distribution Agreement For The United Arab Emirates 28UAE 29 6255 3Custom Spine Launches Pathway AVID and Regent ACP at NASS 6251 1Custom Spine Launches Pathway AVID and Regent ACP at NASS 6251 2
...ngary, Oct. 15 ,Forest Laboratories, Inc. (NYSE: ...ry top-line results from a U.S. conducted randomiz...y of RGH-188, a novel,antipsychotic, in 389 schizo...ndpoint was change from baseline to Week 6 on the ...GH-188 demonstrated a nominally,statistically sign...
...tiveness for weight control in patients with type ...ication, OWINGS MILLS, Md., Oct. 15 Medifast, In...ucted by researchers at the,Johns Hopkins Universi...pted for publication in a peer-reviewed journal wh...e. The study compared Medifast,s effectiveness,for...
Other Medicine Technology:Forest Laboratories, Inc. and Gedeon Richter Announce Results of Phase II-B Study for RGH-188 as a Treatment for Schizophrenia 2Forest Laboratories, Inc. and Gedeon Richter Announce Results of Phase II-B Study for RGH-188 as a Treatment for Schizophrenia 3Forest Laboratories, Inc. and Gedeon Richter Announce Results of Phase II-B Study for RGH-188 as a Treatment for Schizophrenia 4Medifast, Inc. Announces Acceptance for Publication of Clinical Efficacy Study 2
(Date:11/30/2009)...DGEWATER, N.J., Nov. 30 Advanced H...of meeting logistics, speaker programs and commerc...iences industry, announced it has been named the s...Z, New Jersey,s leading statewide business newspap...esses that have made significant contributions to ...
(Date:11/30/2009)...CAGO, Nov. 30 Physicians at Beth I...oday on results of a study demonstrating the poten...aphy (cCTA) by Rcadia,s COR Analyzer System® ...enosis in hospital emergency department (ED ) pati... system to enhance the use of cCTA has potential t...
(Date:11/30/2009)...ers for Disease Control and Prevention estimate th...es are infected with HIV/AIDS. New research from N...those infected are minorities and do not have heal...al strategy to facilitate education and prevention..., The research, which analyzed 90,000 HIV patient...
(Date:11/30/2009)...en asked to inhibit their response to a "cocaine-c...e, able to suppress activity in brain regions link...e U.S. Department of Energy,s Brookhaven National ...oming issue of NeuroImage , suggest that clinical...tory responses could help cocaine abusers stop usi...
(Date:11/30/2009)...elpings of gravy and dessert at the holiday table ...viously thought. According to a new research repor... ( http://www.fasebj.org ), a diet that is high in...ultimately cause our bodies to store too much fat....my as the already difficult task of converting hig...
Breaking Medicine News(10 mins):Health News:Advanced Health Media Honored at NJ Finest Award Ceremony 2Health News:Rcadia COR Analyzer(R) System Demonstrates Potential in Emergency Department Triage of Chest Pain Patients at Low to Moderate Risk of Coronary Artery Disease 2Health News:Rcadia COR Analyzer(R) System Demonstrates Potential in Emergency Department Triage of Chest Pain Patients at Low to Moderate Risk of Coronary Artery Disease 3Health News:Research highlights need for national HIV strategy 2Health News:Brain scan study shows cocaine abusers can control cravings 2Health News:Brain scan study shows cocaine abusers can control cravings 3Health News:Western diets turn on fat genes 2
...o Scientists has revealed that a Husband’s comfort...d women. // According to the study, those who esta...uching their husband’s hands, feel immediate relie...ef from a loved one’s touch recorded intense sooth...
...tain parts of Canada do not have access to drugs w... the country’s Cancer Advocacy Coalition of Canada... some of the provinces are unwilling to pay for th...e treatment with the drug costs as much as $60 tho...
...ut still we have to eradicate the disease from our... awareness regarding the // transmission of the ba...r treating the disease. Indian Health Minister...ients in India but the incidence of Leprosy is con...
...prosy is decreasing to about 0.95 cases per 10,000...hat leprosy is eliminated from India. // But this ...an that the disease is completely eliminated but t... of the disease at about 2.11 per 10,000, along wi...
...ed tomography (SPECT), a simple diagnostic modalit...s, a treatment given for back pain. // It can pred... and who will not. The results of this valuable st... demonstrating the abnormal activity of cells in t...
...y Copeman Healthcare Inc.’s may face charges of le... an initial consultation fee of $3,500. // The Ont...dum to the Health ministry to take action against ...aimed at setting up profit based clinics providing...
Other Medicine News:Health News:Handy Touch - A Wand to Bust Stressful Situations 2Health News:SPECT Can Help Predict Treatment Outcome In Patients With Low Back Pain 2
...ique left ventricular assist device that helps the...used in a small group of patients with severe chro...roved Feasibility Study. The patient can turn the ...e for minutes or hours. The Kantrowitz CardioVad i...
ADVIA Autoslide Slide Maker Stainer
...he world's first minimally-invasive epicardial lea...dial Lead Implant Tool, which has been cleared for...ptions available to implanting physicians who plac...g pacemaker implants. The tool furthers the trend ...
T600 Treadmill
Medicine Products: